Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,990 | -34,790 | -31,600 | -3,730 | -19,190 |
| Depreciation Amortization | 720 | 530 | 360 | 160 | 1,310 |
| Other Working Capital | -500 | 190 | 330 | 470 | 1,360 |
| Other Operating Activity | 22,140 | 24,550 | 24,270 | 230 | 130 |
| Operating Cash Flow | $-11,630 | $-9,520 | $-6,640 | $-2,870 | $-16,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -80 | -70 | -50 | -30 | -660 |
| Other Investing Activity | 50 | 50 | 42 | 34 | 50 |
| Investing Cash Flow | $-30 | $-20 | $-8 | $4 | $-610 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 3,750 | 4,700 | 4,690 | 4,740 | -2,970 |
| Financing Cash Flow | $3,750 | $4,700 | $4,690 | $4,740 | $-2,970 |
| Beginning Cash Position | 14,120 | 14,120 | 14,120 | 14,120 | 34,090 |
| End Cash Position | 6,200 | 9,280 | 12,170 | 15,990 | 14,120 |
| Net Cash Flow | $-7,910 | $-4,840 | $-1,950 | $1,870 | $-19,970 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,630 | -9,520 | -6,640 | -2,870 | -16,390 |
| Free Cash Flow | -11,630 | -9,520 | -6,640 | -2,870 | -16,390 |